Early Economic Models Pay Off

August 22, 2017
Developing an economic model early in the product development cycle makes it possible to identify potential cost-effectiveness and data issues early enough to be able to address them cost-efficiently. In extreme cases, such a model can help a company avoid investing significant resources in a drug that lacks any
realistic chance of achieving commercial success. This article shares three examples of cases where early-stage
economic models helped clients improve their reimbursement approval.
Previous Flipbook
Today's Gold Standard: Product Approval Demands Real-World Evidence
Today's Gold Standard: Product Approval Demands Real-World Evidence

Key strategies for providing real-world evidence to help ensure your product will reach its full potential.

Next Flipbook
Safety Services: Supporting Emerging Companies with an End-to-End Solution
Safety Services: Supporting Emerging Companies with an End-to-End Solution

Highly efficient, compliant global pharmacovigilance processes to support organizations of all sizes.

×

Speak to a Parexel® Biotech expert today!

First Name
Last Name
Job Title
Company Name
Country
Tell us how we can help
Thank you!
Error - something went wrong!